- Home
- OCS vs FNA Comparison
OCS vs FNA Comparison
Compare OCS & FNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- FNA
- Stock Information
- Founded
- OCS 2003
- FNA 2010
- Country
- OCS Switzerland
- FNA United States
- Employees
- OCS N/A
- FNA N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OCS Health Care
- FNA Health Care
- Exchange
- OCS Nasdaq
- FNA Nasdaq
- Market Cap
- OCS 717.3M
- FNA 852.1M
- IPO Year
- OCS N/A
- FNA 2021
- Fundamental
- Price
- OCS $17.31
- FNA $10.60
- Analyst Decision
- OCS Strong Buy
- FNA Strong Buy
- Analyst Count
- OCS 5
- FNA 5
- Target Price
- OCS $29.20
- FNA $15.60
- AVG Volume (30 Days)
- OCS 39.4K
- FNA 550.3K
- Earning Date
- OCS 11-07-2024
- FNA 11-12-2024
- Dividend Yield
- OCS N/A
- FNA N/A
- EPS Growth
- OCS N/A
- FNA N/A
- EPS
- OCS N/A
- FNA N/A
- Revenue
- OCS $1,027,571.00
- FNA $244,995,000.00
- Revenue This Year
- OCS $6.87
- FNA $18.58
- Revenue Next Year
- OCS $884.16
- FNA $14.85
- P/E Ratio
- OCS N/A
- FNA N/A
- Revenue Growth
- OCS N/A
- FNA 18.16
- 52 Week Low
- OCS $10.11
- FNA $4.65
- 52 Week High
- OCS $18.00
- FNA $14.79
- Technical
- Relative Strength Index (RSI)
- OCS 68.45
- FNA 60.03
- Support Level
- OCS $15.45
- FNA $10.19
- Resistance Level
- OCS $17.92
- FNA $11.00
- Average True Range (ATR)
- OCS 0.50
- FNA 0.51
- MACD
- OCS 0.17
- FNA -0.13
- Stochastic Oscillator
- OCS 81.42
- FNA 43.20
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About FNA Paragon 28 Inc.
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.